The current financial score of Inogen Inc is 7.40. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 95.08M, representing a year-over-year increase of 3.04%, while its net profit experienced a year-over-year increase of 7.27%.
The current valuation score of Inogen Inc is 9.09. Its current P/E ratio is -5.62, which is -86.99% below the recent high of -0.73 and -52.91% above the recent low of -8.60.
The current earnings forecast score of Inogen Inc is 8.00. The average price target is 12.00, with a high of 12.00 and a low of 12.00.
The current price momentum score of Inogen Inc is 3.47. Currently, the stock price is trading between the resistance level at 5.51 and the support level at 4.91, making it suitable for range-bound swing trading.
The current institutional shareholding score of Inogen Inc is 7.00. The latest institutional shareholding proportion is 75.89%, representing a quarter-over-quarter increase of 4.39%. The largest institutional shareholder is James Simons, holding a total of 476.70K shares, representing 0.00% of shares outstanding, with 46.31% decrease in holdings.
The current risk assessment score of Inogen Inc is 6.17. The company's beta value is 1.61. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.